Cooley advised the underwriters on Audentes Therapeutics’ $86.3 million shelf-takedown offering of 5,955,151 shares of common stock, which includes 755,151 shares purchased pursuant to the underwriters’…
Audentes’ $86 Million Shelf-Takedown Offering
![](https://globallegalchronicle.com/wp-content/uploads/2017/05/fd5ed051eb.jpeg)